ATOPIC DERMATITIS (AD)
Clinical trials for ATOPIC DERMATITIS (AD) explained in plain language.
Never miss a new study
Get alerted when new ATOPIC DERMATITIS (AD) trials appear
Sign up with your email to follow new studies for ATOPIC DERMATITIS (AD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New eczema pill shows promise in major trial
Disease control ENROLLING_BY_INVITATIONThis study tests an experimental tablet called QY201 for adults with moderate to severe atopic dermatitis (eczema). About 460 participants will take either QY201 or a placebo daily for 16 weeks. The goal is to see if the drug can significantly clear skin and reduce itch, with a f…
Matched conditions: ATOPIC DERMATITIS (AD)
Phase: PHASE3 • Sponsor: E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd. • Aim: Disease control
Last updated May 05, 2026 11:54 UTC
-
New pill shows promise for severe eczema in early trial
Disease control OngoingThis study tests an experimental tablet called HSK44459 in 150 adults with moderate-to-severe atopic dermatitis (eczema). The goal is to see if the drug can reduce skin redness, itching, and rash over 12 weeks compared to a placebo. Participants must have had eczema for at least …
Matched conditions: ATOPIC DERMATITIS (AD)
Phase: PHASE2 • Sponsor: Xizang Haisco Pharmaceutical Co., Ltd • Aim: Disease control
Last updated May 04, 2026 16:18 UTC
-
New drug ATTO1310 tested for itch relief – first human trial underway
Symptom relief OngoingThis early-stage study tests ATTO1310, an experimental drug, for safety in healthy adults, people with eczema (atopic dermatitis), and those with long-term itching. About 108 participants will receive either the drug or a placebo and be monitored for side effects. The goal is to …
Matched conditions: ATOPIC DERMATITIS (AD)
Phase: PHASE1 • Sponsor: Attovia Therapeutics Inc • Aim: Symptom relief
Last updated May 13, 2026 15:58 UTC
-
Can a cholesterol cream soothe eczema?
Symptom relief ENROLLING_BY_INVITATIONThis study tests a cream made with 2% cholesterol to see if it helps repair the skin barrier and reduce symptoms like dryness and itching in children aged 7–17 with mild to moderate eczema. About 30 participants will apply the cream or a placebo twice daily for 12 weeks. Research…
Matched conditions: ATOPIC DERMATITIS (AD)
Phase: NA • Sponsor: Institute of Dermatology, Thailand • Aim: Symptom relief
Last updated May 08, 2026 12:03 UTC
-
New eczema drug candidate tested in healthy people for first time
Knowledge-focused OngoingThis early-stage study tests a new medicine called GB-7624 in 40 healthy adults to see if it is safe and how the body processes it. The study has two parts: one group gets a single dose, and another gets two doses over two weeks. This research is a first step toward possibly trea…
Matched conditions: ATOPIC DERMATITIS (AD)
Phase: PHASE1 • Sponsor: Generate Biomedicines • Aim: Knowledge-focused
Last updated May 17, 2026 04:17 UTC